Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Life Science Development topic
No spam. Unsubscribe anytime.
Planning Commission approves 1450 Owen life‑science building and office allocation in Mission Bay
Summary
The commission granted general‑plan findings and allocated up to 49,999 square feet of small‑office cap to allow a 7‑story, lab‑heavy building at 1450 Owen Street; staff and the project sponsor cited infrastructure fees, school contributions and community benefits; the vote was unanimous 7‑0.
The Planning Commission on Nov. 19 approved general‑plan findings and a small‑office allocation to enable a new life‑science building at 1450 Owen Street in Mission Bay.
Planning staff described amendments to the Mission Bay South redevelopment plan and design for development to permit a lab‑focused project with roughly 131,000 gross square feet of laboratory space, just under 50,000 gross square feet of office and about 2,600 square feet of ground‑floor retail adjacent to a new entry plaza. "We believe this is an appropriate location for office and laboratory use," staff said, citing the site's proximity to the UCSF campus and existing Mission Bay amenities and transportation links.
Teresa Nemeth, Executive Vice President at Alexandria Real Estate Equities, presented project design and community benefits, including development fees for transportation and housing, additional contributions for childcare and a Mello‑Roos district contribution to park operations, and discussions with the San Francisco Unified School District about a potential school endowment and pathways program.
Public comment included endorsements from local business groups, BioComm (state life‑sciences association) and construction trade unions highlighting job creation and industry demand. After questions and a motion to adopt the staff findings, the commission approved the findings and the office allocation unanimously, 7‑0.
Next steps: approvals tied to redevelopment plan amendments will also proceed to the Board of Supervisors and related successor‑agency actions.
